Linagliptin Tablets 5?mg – 7 Tablets Price comparison

描述

Linagliptin Tablets Description

Product name: Linagliptin tablets
Packing specification: 5mg*7 tablets ? Product dosage form: tablets ? Packaging unit: bottle/box
Approval number: National Medicine Standard H20213378 ? Drug standard code: 86900841000279
Manufacturer: Yangtze River Pharmaceutical Group Shanghai Haini Pharmaceutical Co., Ltd.
Product barcode: 6931640900068

What is Linagliptin?

Linagliptin is a potent oral DPP?4 (dipeptidyl peptidase?4) inhibitor, used clinically to regulate blood sugar in Type?2 Diabetes Mellitus (T2DM) by enhancing levels of active incretins?zh.wikipedia.org+2zh.wikipedia.org+2bydrug.pharmcube.com+2pharm.ncmi.cn+12zh.wikipedia.org+12zh.wikipedia.org+12. Its therapeutic advantages include once?daily dosing, low hypoglycemia risk, and no need for dosage adjustment in renal impairment due to biliary elimination?.

This domestic product, marketed as HuYou or RuLing, is produced by Yangtze River Pharmaceutical Group’s Shanghai Henley Pharma, under NMPA approval number H20213378 with product code 86900841000279 and barcode 6931640900068.

? Product Specifications

? Mechanism of Action & Key Benefits

• Selective DPP?4 Inhibition: Increases endogenous GLP?1 and GIP, promoting insulin secretion and suppressing glucagon in a glucose-dependent way?.

• Pharmacokinetics: High oral bioavailability (~30%), strong plasma protein binding (75–99%), and long half-life enable once-daily dosing?.

• Renal Safety: Cleared mainly via bile; no dose adjustment needed in renal impairment?.

• Clinical Tolerability: Minimal hypoglycemia when used alone; mild adverse events may include headache or upper respiratory infections?.

? Why Choose HuYou/RuLing Linagliptin?

• Reputable Manufacturer: Produced by Yangtze River Pharmaceutical Group

• Approved & Traceable: NMPA-approved with full batch traceability

• Lab-ready Packaging: 7-tablet bottles ideal for study protocols

• Research-grade Quality: Consistent formulation and documentation for pharmacological studies

? Related Research Substances

• Sitagliptin Phosphate Tablets (100?mg) – Jianovi

• Vildagliptin Tablets (Weitangning 50?mg)

• Empagliflozin 10?mg Tablets (SGLT?2 Inhibitor)

? Summary

HuYou/RuLing Linagliptin 5?mg Tablets provide a high-quality research-grade DPP?4 inhibitor option with robust production credentials, stable packaging, and full regulatory traceability. Ideal for labs exploring metabolic and endocrine research.

?? Reminder: For laboratory research or analytical use only — not for human consumption or therapy.